JP2004531235A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2004531235A5 JP2004531235A5 JP2002566355A JP2002566355A JP2004531235A5 JP 2004531235 A5 JP2004531235 A5 JP 2004531235A5 JP 2002566355 A JP2002566355 A JP 2002566355A JP 2002566355 A JP2002566355 A JP 2002566355A JP 2004531235 A5 JP2004531235 A5 JP 2004531235A5
- Authority
- JP
- Japan
- Prior art keywords
- polypeptide
- polynucleotide
- seq
- sequence encoding
- dna sequence
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 229920001184 polypeptide Polymers 0.000 claims 54
- 102000004196 processed proteins & peptides Human genes 0.000 claims 54
- 108090000765 processed proteins & peptides Proteins 0.000 claims 54
- 108091033319 polynucleotide Proteins 0.000 claims 23
- 102000040430 polynucleotide Human genes 0.000 claims 23
- 239000002157 polynucleotide Substances 0.000 claims 23
- 108091028043 Nucleic acid sequence Proteins 0.000 claims 8
- 239000000203 mixture Substances 0.000 claims 8
- 230000000890 antigenic effect Effects 0.000 claims 7
- 230000002163 immunogen Effects 0.000 claims 7
- FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 claims 6
- 230000000295 complement effect Effects 0.000 claims 6
- 239000012634 fragment Substances 0.000 claims 6
- 206010061372 Streptococcal infection Diseases 0.000 claims 4
- 241000194017 Streptococcus Species 0.000 claims 3
- 125000000539 amino acid group Chemical group 0.000 claims 3
- 239000012472 biological sample Substances 0.000 claims 3
- 238000000034 method Methods 0.000 claims 3
- 230000000069 prophylactic effect Effects 0.000 claims 3
- 230000001225 therapeutic effect Effects 0.000 claims 3
- 208000031729 Bacteremia Diseases 0.000 claims 2
- 208000035143 Bacterial infection Diseases 0.000 claims 2
- 108020004414 DNA Proteins 0.000 claims 2
- 201000000297 Erysipelas Diseases 0.000 claims 2
- 206010021531 Impetigo Diseases 0.000 claims 2
- 206010028885 Necrotising fasciitis Diseases 0.000 claims 2
- 201000007100 Pharyngitis Diseases 0.000 claims 2
- 206010039587 Scarlet Fever Diseases 0.000 claims 2
- 241000193996 Streptococcus pyogenes Species 0.000 claims 2
- 125000003275 alpha amino acid group Chemical group 0.000 claims 2
- 239000000427 antigen Substances 0.000 claims 2
- 102000036639 antigens Human genes 0.000 claims 2
- 108091007433 antigens Proteins 0.000 claims 2
- 208000022362 bacterial infectious disease Diseases 0.000 claims 2
- 201000007970 necrotizing fasciitis Diseases 0.000 claims 2
- 206010040070 Septic Shock Diseases 0.000 claims 1
- 206010044248 Toxic shock syndrome Diseases 0.000 claims 1
- 231100000650 Toxic shock syndrome Toxicity 0.000 claims 1
- 239000002671 adjuvant Substances 0.000 claims 1
- 238000012258 culturing Methods 0.000 claims 1
- 238000001514 detection method Methods 0.000 claims 1
- 238000002405 diagnostic procedure Methods 0.000 claims 1
- 239000003085 diluting agent Substances 0.000 claims 1
- 201000010099 disease Diseases 0.000 claims 1
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 claims 1
- 239000003937 drug carrier Substances 0.000 claims 1
- 238000004519 manufacturing process Methods 0.000 claims 1
- 239000008194 pharmaceutical composition Substances 0.000 claims 1
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US26984001P | 2001-02-21 | 2001-02-21 | |
| PCT/CA2002/000207 WO2002066650A2 (en) | 2001-02-21 | 2002-02-21 | Streptococcus pyogenes polypeptides and corresponding dna fragments |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2004531235A JP2004531235A (ja) | 2004-10-14 |
| JP2004531235A5 true JP2004531235A5 (https=) | 2005-12-22 |
| JP4281861B2 JP4281861B2 (ja) | 2009-06-17 |
Family
ID=23028867
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002566355A Expired - Fee Related JP4281861B2 (ja) | 2001-02-21 | 2002-02-21 | Ｓｔｒｅｐｔｏｃｏｃｃｕｓ ｐｙｏｇｅｎｅｓポリペプチドおよび対応するｄｎａフラグメント |
Country Status (10)
| Country | Link |
|---|---|
| US (2) | US7482012B2 (https=) |
| EP (1) | EP1362106B1 (https=) |
| JP (1) | JP4281861B2 (https=) |
| AT (1) | ATE456659T1 (https=) |
| AU (1) | AU2002234455C1 (https=) |
| BR (1) | BRPI0207447B1 (https=) |
| CA (1) | CA2438921C (https=) |
| DE (1) | DE60235223D1 (https=) |
| ES (1) | ES2338637T3 (https=) |
| WO (1) | WO2002066650A2 (https=) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| AU2002216863B8 (en) * | 2000-12-21 | 2008-03-20 | Id Biomedical Corporation | Streptococcus pyogenes antigens and corresponding DNA fragments |
| AU2008207670B2 (en) * | 2001-04-13 | 2011-06-16 | Wyeth | Surface proteins of streptococcus pyogenes |
| JP2005503774A (ja) * | 2001-05-02 | 2005-02-10 | シャイアー バイオケム インコーポレイテッド | グループｂストレプトコッカスの抗原および対応ｄｎａフラグメント |
| IL162857A0 (en) * | 2002-01-15 | 2005-11-20 | Bio Life Science Forschungs & Entwicklungsgesellschaft Mbh | Oral vaccination |
| EP2287315A1 (en) * | 2003-03-04 | 2011-02-23 | Intercell AG | Streptococcus pyogenes antigens |
| EP2311988A1 (en) | 2003-04-15 | 2011-04-20 | Intercell AG | S. pneumoniae antigens |
| WO2005017093A2 (en) * | 2003-08-15 | 2005-02-24 | Id Biomedical Corporation | Polypeptides of streptococcus pyogenes |
| US20090277790A1 (en) | 2006-04-14 | 2009-11-12 | Nec Corporation | Individual identification method and apparatus |
Family Cites Families (9)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6040144A (en) * | 1997-07-25 | 2000-03-21 | Mount Sinai School Of Medicine | Procedure for preparing gene expression libraries enriched for secretory protein genes |
| US6033673A (en) * | 1998-03-18 | 2000-03-07 | The Administrators Of Tulane Educational Fund | Double mutant enterotoxin for use as an adjuvant |
| GB9807890D0 (en) * | 1998-04-09 | 1998-06-10 | Actinova Ltd | Peptides |
| GB9921125D0 (en) | 1999-09-07 | 1999-11-10 | Microbial Technics Limited | Proteins |
| CA2881568C (en) | 2000-10-27 | 2019-09-24 | Novartis Vaccines And Diagnostics, Inc. | Nucleic acids and proteins from streptococcus groups a & b |
| FR2824074A1 (fr) | 2001-04-26 | 2002-10-31 | Pasteur Institut | Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques |
| JP2005503774A (ja) | 2001-05-02 | 2005-02-10 | シャイアー バイオケム インコーポレイテッド | グループｂストレプトコッカスの抗原および対応ｄｎａフラグメント |
| GB0210128D0 (en) | 2002-05-02 | 2002-06-12 | Chiron Spa | Nucleic acids and proteins from streptococcus groups A & B |
| EP2287315A1 (en) | 2003-03-04 | 2011-02-23 | Intercell AG | Streptococcus pyogenes antigens |
-
2002
- 2002-02-21 BR BRPI0207447A patent/BRPI0207447B1/pt not_active IP Right Cessation
- 2002-02-21 US US10/078,531 patent/US7482012B2/en not_active Expired - Lifetime
- 2002-02-21 DE DE60235223T patent/DE60235223D1/de not_active Expired - Lifetime
- 2002-02-21 EP EP02701124A patent/EP1362106B1/en not_active Expired - Lifetime
- 2002-02-21 WO PCT/CA2002/000207 patent/WO2002066650A2/en not_active Ceased
- 2002-02-21 JP JP2002566355A patent/JP4281861B2/ja not_active Expired - Fee Related
- 2002-02-21 CA CA2438921A patent/CA2438921C/en not_active Expired - Fee Related
- 2002-02-21 AU AU2002234455A patent/AU2002234455C1/en not_active Ceased
- 2002-02-21 ES ES02701124T patent/ES2338637T3/es not_active Expired - Lifetime
- 2002-02-21 AT AT02701124T patent/ATE456659T1/de not_active IP Right Cessation
-
2009
- 2009-01-12 US US12/352,518 patent/US7883706B2/en not_active Expired - Fee Related
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| Brodeur et al. | Identification of group B streptococcal Sip protein, which elicits cross-protective immunity | |
| US8529911B2 (en) | Small Streptococcus pyogenes antigens and their use | |
| CA2356836A1 (en) | Novel streptococcus antigens | |
| EA006232B1 (ru) | Стрептококковые антигены | |
| JPH07508649A (ja) | マイコバクテリアの膜−関連免疫原 | |
| CA2439428A1 (en) | Molecular mimetics of meningococcal b epitopes which elicit functionally active antibodies | |
| JP2002167399A (ja) | 肺炎球菌表面プロテインａのエピトープ領域 | |
| US5352588A (en) | Streptococcal immunoglobulin a binding protein encoded by emmL2.2 | |
| CA2413576A1 (en) | Streptococcus pyogenes antigens | |
| EP2120984A2 (en) | Protective proteins of s. agalactiae, combinations thereof and methods of using the same | |
| JP2004531235A5 (https=) | ||
| JP2005535287A5 (https=) | ||
| CA2475821A1 (en) | Group b streptococcus antigens | |
| CA2438921A1 (en) | Streptococcus pyogenes polypeptides and corresponding dna fragments | |
| CA2432525A1 (en) | Streptococcus pyogenes antigens and corresponding dna fragments | |
| CA2466474A1 (en) | Compositions comprising spa-1, spa-2 and spa-3, polypeptides and related uses | |
| JP2001517091A (ja) | Ｈｅｌｉｃｏｂａｃｔｅｒ ｐｙｌｏｒｉについての抗原性組成物および検出方法 | |
| JP2005524387A5 (https=) | ||
| EP0917471A2 (en) | Treatment and diagnosis of infections of gram positive cocci | |
| JP2005501534A5 (https=) | ||
| KR101270662B1 (ko) | 브루셀라 아보투스의 ２６ｋＤａ 재조합 항원 단백질 및 ＬＰＳ를 이용한 진단 키트 | |
| JP2005508146A5 (https=) | ||
| WO2011009771A2 (en) | Immunogenic and therapeutic compositions for streptococcus suis | |
| JP3814844B2 (ja) | クラミジア・ニューモニエの抗原ポリペプチド、それをコードするｄｎａ、そのｄｎａを含む組換えベクター、その組換えベクターを含む形質転換体、及び抗クラミジア・ニューモニエ抗体の製造方法 | |
| JP2005507653A5 (https=) |